Holen Sie sich die Stockscreener-App
51.63
0.39%
-0.20
Handel nachbörslich:
51.63
Schlusskurs vom Vortag:
$51.83
Offen:
$52.17
24-Stunden-Volumen:
663.96K
Relative Volume:
1.33
Marktkapitalisierung:
$3.68B
Einnahmen:
$751.00K
Nettoeinkommen (Verlust:
$-74.57M
KGV:
-46.80
EPS:
-1.1031
Netto-Cashflow:
$-55.52M
1W Leistung:
-4.16%
1M Leistung:
+5.37%
6M Leistung:
+134.47%
1J Leistung:
+202.11%
1-Tages-Spanne:
$50.80
$54.05
1-Wochen-Bereich:
$50.80
$56.74
52-Wochen-Spanne:
$12.56
$58.90
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
51.63 | 3.68B | 751.00K | -74.57M | -55.52M | -1.1031 |
ISRG
Intuitive Surgical Inc
|
405.18 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.82 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
222.00 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.47 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.70 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-07 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily
Pulse Biosciences stock reports 100 patient trial milestone - AD HOC NEWS
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday - benzinga.com
BTIG initiates Pulse Biosciences stock coverage with buy rating By Investing.com - Investing.com Australia
BTIG initiates Pulse Biosciences stock coverage with buy rating - Investing.com India
BTIG Initiates Pulse Biosciences at Buy With $70 Price Target - finance.yahoo.com
BTIG initiates coverage of Pulse Biosciences with Buy rating, $70 price target - TradingView
PLSE Initiated by BTIG -- Price Target Set at $70.00 - GuruFocus
Is Pulse Biosciences (PLSE) Fully Valued As Its Thyroid Trial Reaches 100 Patients? - simplywall.st
Pulse Biosciences, Inc (PLSE) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings Amidst Volatile Market Conditions - DirectorsTalk Interviews
Pulse Biosciences Launches New ATM Equity Program - The Globe and Mail
Pulse Biosciences (NASDAQ: PLSE) Launches $85M ATM Offering at $54.21 Per Share - Kalkine Media
Form 8K Pulse Biosciences Inc For: 15 September By Investing.com - Investing.com Australia
Pulse Biosciences Opens New $85 Million At-the-Market Stock Offering - Minichart
Pulse Biosciences enters $85 million equity distribution agreement with Mizuho - Investing.com
Pulse Biosciences completes enrollment in thyroid nodule study By Investing.com - Investing.com Nigeria
Pulse Biosciences Finalizes Enrollment for PRECISE-BTN Trial Evaluating nPulse Vybrance System - Kalkine Media
Pulse Biosciences Completes Enrollment In The PRECISE-BTN Clinical Study Evaluating The nPulse Vybrance Percutaneous Electrode System For Symptomatic Benign Thyroid Nodules - marketscreener.com
Pulse Biosciences (PLSE) Advances PRECISE-BTN Trial as Valuation Reflects High Growth Expectations - GuruFocus
Pulse Biosciences completes enrollment in thyroid nodule study - Investing.com
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules - Business Wire
Why is Pulse Biosciences stock surging today? By Investing.com - Investing.com Nigeria
Pulse Biosciences stock hits all-time high at 56.15 USD By Investing.com - Investing.com Nigeria
Freedom Capital initiates Pulse Biosciences stock with buy rating By Investing.com - Investing.com Australia
Why Pulse Biosciences Stock Popped Today - theglobeandmail.com
Freedom Capital Markets Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $73 - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Pulse Biosciences stock hits all-time high at 56.15 USD - investing.com
$Pulse Biosciences (PLSE.US)$ the squeeze is onnnnnnnn - Moomoo
PLSE Initiates Coverage by Freedom Capital Markets -- Price Targ - GuruFocus
Freedom Capital initiates Pulse Biosciences stock with buy rating - investing.com
PLSE Q2 2026 Earnings: Narrower-Than-Expected Loss Yields 1.96% Surprise But Shares DeclineEPS Miss Report - careplusvn.com
(PLSE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Pulse Biosciences Stock Price Forecast. Should You Buy PLSE? - StockInvest.us
Pulse Biosciences stock holds steady as investors eye recent clinical and financial progress - AD HOC NEWS
Pulse Biosciences (PLSE) Grants Equity Awards to New Hires Amid High Price-to-Sales Valuation - GuruFocus
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Pulse Biosciences Inc (DE) (PLSE) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock By Investing.com - Investing.com Australia
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock - Investing.com India
COO pays nearly $50 a share for Pulse Biosciences (NASDAQ: PLSE) - Stock Titan
Pulse Biosciences Inc (DE) (PLSE) Peer Comparison – Compare with Others - Value Research
$Pulse Biosciences (PLSE.US)$ New ATH 🔥 - Moomoo
Pulse Biosciences Reports Teplitsky Liane Rae as New Insider COO - Kalkine Media
Pulse Biosciences stock hits new high as insider buying fuels rally - AD HOC NEWS
Pulse Biosciences stock hits all-time high at 51.0 USD - Investing.com
Pulse Biosciences stock hits all-time high at 51.0 USD By Investing.com - Investing.com Canada
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):